Aria CV snags $31m Series B
St. Paul, Minnesota-based Aria CV Inc, a developer of medical devices treating pulmonary arterial hypertension, has secured $31 million in Series B financing.
St. Paul, Minnesota-based Aria CV Inc, a developer of medical devices treating pulmonary arterial hypertension, has secured $31 million in Series B financing.
Copyright PEI Media
Not for publication, email or dissemination